Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $492.91 ($4.7M) on 2026-09-18, disclosed to the SEC on 2026-09-21.
Scheduled sale ($4.7M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $492.91 | 248 | $122K | 2.6% |
| 2 | $493.78 | 2,216 | $1.1M | 23.3% |
| 3 | $494.70 | 4,269 | $2.1M | 44.9% |
| 4 | $495.66 | 2,330 | $1.2M | 24.6% |
| 5 | $496.64 | 277 | $138K | 2.9% |
| 6 | $498.25 | 160 |
| $80K |
| 1.7% |
| Total | $494.79 avg | 9,500 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |